Skip Navigation

Nucleic Acids Research 2006 34(8):2328-2339; doi:10.1093/nar/gkl317
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1668K) Freely available
Right arrow Screen PDF (1679K) Freely available
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ennifar, E.
Right arrow Articles by Marquet, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ennifar, E.
Right arrow Articles by Marquet, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published online 5 May 2006

© The Author 2006. Published by Oxford University Press. All rights reserved
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org


Article

Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell

Eric Ennifar1, Jean-Christophe Paillart1, Anne Bodlenner2, Philippe Walter1, Jean-Marc Weibel2, Anne-Marie Aubertin3, Patrick Pale2, Philippe Dumas1,* and Roland Marquet1,*

1 UPR 9002 du CNRS conventionnée à l'Université Louis Pasteur, IBMC 15 rue René Descartes, 67084, Strasbourg cedex, France 2 UMR 7123 CNRS—Université Louis Pasteur, Institut Le Bel 4 rue Blaise Pascal, BP 1032/F, 67070, Strasbourg cedex, France 3 UMR 544 INSERM—Université Louis Pasteur, Institut de Virologie 3 rue Koberlé, 67000 Strasbourg, France

*To whom correspondence should be addressed. Tel: +33388417002; Fax: +33388602218; Email: P.Dumas{at}ibmc.u-strasbg.fr

*Correspondence may also be addressed to Roland Marquet. Tel: +33388417054; Fax: +33388602218; Email: R.Marquet{at}ibmc.u-strasbg.fr

Received March 15, 2006. Accepted April 12, 2006.

The kissing-loop complex that initiates dimerization of genomic RNA is crucial for Human Immunodeficiency Virus Type 1 (HIV-1) replication. We showed that owing to its strong similitude with the bacterial ribosomal A site it can be targeted by aminoglycosides. Here, we present its crystal structure in complex with neamine, ribostamycin, neomycin and lividomycin. These structures explain the specificity for 4,5-disubstituted 2-deoxystreptamine (DOS) derivatives and for subtype A and subtype F kissing-loop complexes, and provide a strong basis for rational drug design. As a consequence of the different topologies of the kissing-loop complex and the A site, these aminoglycosides establish more contacts with HIV-1 RNA than with 16S RNA. Together with biochemical experiments, they showed that while rings I, II and III confer binding specificity, rings IV and V are important for affinity. Binding of neomycin, paromomycin and lividomycin strongly stabilized the kissing-loop complex by bridging the two HIV-1 RNA molecules. Furthermore, in situ footprinting showed that the dimerization initiation site (DIS) of HIV-1 genomic RNA could be targeted by these aminoglycosides in infected cells and virions, demonstrating its accessibility.


The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RNAHome page
V. Olieric, U. Rieder, K. Lang, A. Serganov, C. Schulze-Briese, R. Micura, P. Dumas, and E. Ennifar
A fast selenium derivatization strategy for crystallization and phasing of RNA structures
RNA, April 1, 2009; 15(4): 707 - 715.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. Puffer, H. Moroder, M. Aigner, and R. Micura
2'-Methylseleno-modified oligoribonucleotides for X-ray crystallography synthesized by the ACE RNA solid-phase approach
Nucleic Acids Res., February 11, 2008; 36(3): 970 - 983.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Bernacchi, S. Freisz, C. Maechling, B. Spiess, R. Marquet, P. Dumas, and E. Ennifar
Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion
Nucleic Acids Res., December 18, 2007; 35(21): 7128 - 7139.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
E. Ennifar, S. Bernacchi, P. Wolff, and P. Dumas
Influence of C-5 halogenation of uridines on hairpin versus duplex RNA folding
RNA, September 1, 2007; 13(9): 1445 - 1452.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.